Search Within

Taha Merghoub

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (48)
  2. GSK Faculty (48)
  3. Human Oncology and Pathogenesis Program (48)
  4. Melanoma and Immunotherapeutics Service (48)
  5. Solid Tumor Oncology Division (48)
  6. Department of Pathology and Laboratory Medicine (34)

More Groups

People
  1. Jedd Wolchok (35)
  2. Alan Houghton (15)
  3. David Solit (14)
  4. Gabrielle Rizzuto (14)
  5. Vinod Balachandran (12)
  6. Cailian Liu (11)

More People

Years
  1. 2023 (4)
  2. 2022 (6)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (3)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer Research (6)
  3. Nature (6)
  4. Cancer Cell (3)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Journal of Experimental Medicine (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (8)
  3. Nature Publishing Group (8)
  4. Cell Press (5)
  5. Biomed Central Ltd (3)
  6. Public Library of Science (3)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Massively parallel sequencing analysis of benign melanocytic naevi
    Journal Article

    Lozada, J. R.; Geyer, F. C.; Selenica, P.; Brown, D.; Alemar, B.; Merghoub, T.; Berger, M. F.; Busam, K. J.; Halpern, A. C.; Weigelt, B.; more...
    Histopathology (2019)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma
    Journal Article

    Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term pancreatic cancer survivors
    Meeting Abstract

    Balachandran, V.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
    Journal Article

    Luksza, M.; Riaz, N.; Makarov, V.; Balachandran, V. P.; Hellmann, M. D.; Solovyov, A.; Rizvi, N. A.; Merghoub, T.; Levine, A. J.; Chan, T. A.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
    Journal Article

    Balachandran, V. P.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • Clonal abundance of tumor-specific CD4(+) T cells potentiates efficacy and alters susceptibility to exhaustion
    Journal Article

    Malandro, N.; Budhu, S.; Kuhn, N. F.; Liu, C.; Murphy, J. T.; Cortez, C.; Zhong, H.; Yang, X.; Rizzuto, G.; Altan-Bonnet, G.; more...
    Immunity (2016)

    Fulltext@MSK | Save
  • Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
    Journal Article

    Wiesner, T.; Lee, W.; Obenauf, A. C.; Ran, L.; Murali, R.; Zhang, Q.; Wong, E. W. P.; Hu, W.; Scott, S. N.; Shah, R. H.; more...
    Nature (2015)

    Fulltext@MSK | Save
  • A retrospective evaluation of vemurafenib as treatment for BRAF-mutant melanoma brain metastases
    Journal Article

    Harding, J. J.; Catalanotti, F.; Munhoz, R. R.; Cheng, D. T.; Yaqubie, A.; Kelly, N.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Lacouture, M. E.; more...
    The Oncologist (2015)

    Fulltext@MSK | Save
  • Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
    Journal Article

    Nissan, M. H.; Pratilas, C. A.; Jones, A. M.; Ramirez, R.; Won, H.; Liu, C.; Tiwari, S.; Kong, L.; Hanrahan, A. J.; Yao, Z.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save